Research on autosomal dominant polycystic kidney disease in China

Chinese Medical Journal

Volumn 119, Issue 22, 2006, Pages 1915-1924

  Dai, Bing ^a   Mei, Chang Lin ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Autosomal dominant polycystic kidney disease; Molecular diagnosis; Pathogenesis; Therapy

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; AZATHIOPRINE; BONE DERIVED GROWTH FACTOR; CHINESE DRUG; CYCLOOXYGENASE 2 INHIBITOR; CYCLOPHOSPHAMIDE; CZ SIMM 001; EKI 785; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; EUPOLYPHAGA SEU STELEOPHAGA; GROWTH FACTOR; IMMUNOSUPPRESSIVE AGENT; PARGANUM STOLONFFERAM BUCH HAM; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PIOGLITAZONE; POLYCYSTIN 1; POLYCYSTIN 2; ROSIGLITAZONE; STEROID; UNCLASSIFIED DRUG; VASCULOTROPIN C; VASOPRESSIN RECEPTOR ANTAGONIST; VASOPRESSIN V2 RECEPTOR;

AUTOSOMAL DOMINANT DISORDER; BIOINFORMATICS; CHINA; CLINICAL STUDY; DECOMPRESSION SURGERY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DRUG MECHANISM; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE MUTATION; GENE SEQUENCE; GENETIC COUNSELING; GENETIC SCREENING; GENOMICS; HUMAN; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; LIFESTYLE; MEDLINE; MOLECULAR DYNAMICS; MUTATIONAL ANALYSIS; NEPHRECTOMY; NONHUMAN; PATHOGENESIS; PROTEOMICS; RENAL REPLACEMENT THERAPY; REVIEW; SEQUENCE ANALYSIS;

EID: 33751428473     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200611020-00012     Document Type: Review

References (58)

1. Perrone RD. Extrarenal manifestations of ADPKD. Kidney Int 1997; 51: 2022-2036.
2. The European Polycystic Kidney Disease Consortium. The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. Cell 1994; 77: 881-894.
3. The International Polycystic Kidney Disease Consortium. Polycystic kidney disease: the complete structure of the PKD1 gene and its protein. Cell 1995; 81:289-298.
4. Mochizuki T, Wu G, Hayashi T, Xenophontos SL, Veldhuisen B, Saris JJ, et al. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 1996; 272: 1339-1342.
5. Paterson AD, Pei Y. Is there a third gene for autosomal dominant polycystic kidney disease? Kidney Int 1998; 54: 1759-1761.
6. Rossetti S, Burton S, Strmecki L, Pond GR, San Millan JL, Zerres K, et al. The position of the polycystic kidney disease 1 (PKD1) gene mutation correlates with the severity of renal disease. J Am Soc Nephrol 2002; 13: 1230-1237.
7. Hateboer N, Veldhuisen B, Peters D, Breuning MH, San-Millan JL, Bogdanova N, et al. Location of mutations within the PKD2 gene influences clinical outcome. Kidney Int 2000; 57:1444-1451.
8. Peters DJ, Breuning MH. Autosomal dominant polycystic kidney disease: modification of disease progression. Lancet 2001; 358: 1439-1444.
9. Guay-Woodford LM. Murine models of polycystic kidney disease: molecular and therapeutic insights. Am J Physiol Renal Physiol 2003; 285: F1034-1049.
10. Grantham JJ. Lillian Jean Kaplan International Prize for advancement in the understanding of polycystic kidney disease. Understanding polycystic kidney disease: a systems. biology approach. Kidney Int 2003; 64: 1157-1162.
11. Wilson PD. Polycystic kidney disease. N Engl J Med 2004; 350:151-164.
12. Cowley BD Jr. Recent advances in understanding the pathogenesis of polycystic kidney disease: therapeutic implications. Drugs 2004; 64: 1285-1294.
13. He S, An S, Jiang H, Yang R, Cao Y. Cyst decapitating decompression operation in polycystic kidney: Preliminary report of 52 cases. Chin Med J 1980; 93: 773-778.
14. Zheng K, Zhao Z, Wu Z. Analysis of 35 cases of polycystic kidneys. Chin J Urol (Chin) 1982; 3: 99-100.
15. Liu YC, Zhang HL, Zhong H, Zhu SL, Wang R, Wang HY. Systemic manifestation of adult polycystic kidney disease: An analysis of 205 cases. Chin J Int Med (Chin) 1995; 34:612-615.
16. Ding L, Zhang S, Qiu W, Xiao C, Wu S, Zhang G, et al. Novel mutations of PKD1 gene in Chinese patients with autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 2002; 17: 75-80.
17. Xu CG, Mei CL, Zhang LM. Establishment and identification of ADPKD cyst-lining epithelial cell lines. J Nephrol Dialy Tranplant (Chin) 2000; 9: 142-145.
18. Zhao HD, Mai CL, Shen XF, Sun TM, Zhang SZ, Wang WJ, et al. Preparation of monoclonal antibody against LRR-WSC domain of polycystin-1 and distribution of polycystin-1 in kidney tissues and kidney cell lines. Chin J Lab Med (Chin) 2004; 27: 518-522.
19. Piontek KB, Huso DL, Grinberg A, Liu L, Bedja D, Zhao H, et al. A functional floxed allele of Pkd1 that can be conditionally inactivated in vivo. J Am Soc Nephrol 2004; 15:3035-3043.
20. Mei CL, Zhang WL, Ge SY, Xu CG, Sun TM, Song J. The difference of gene expression profile in polycystic kidney tissue detedcted by cDNA microarray. J Nephrol Dialy Transplant (Chin) 2002; 11: 307-322.
21. Zhang WL, Wu YM, Ge SY, Mei CL. Detection of differentially expressed genes in human autosomal dominant polycystic kidney tissue. Chin J Med Genet (Chin) 2005; 22: 705-708.
22. Zhang Y, Mei CL, Yu F, Shen XF, Huang Y, Liu YW, et al. Comparative proteomic analysis of urine of autosomal dominant polycystic kidney disease patients and normal adults. Chin J Nephrol (Chin) 2005; 21: 335-340.
23. Yuan AH, Mei CL. Expression of hepatocyte growth factor and its receptor in autosomal dominant polycystic kidney disease cyst-lining epithelial cells. Chin J Nephrol (Chin) 2003; 19: 228-234.
24. Yuan AH, Mai CL. Effects of hepatocyte growth factor on proliferation of autosomal dominant polycystic kidney disease cyst-lining epithelial cells and its signal transduction mechanism. Chin J Nephrol (Chin) 2004; 20: 94-97.
25. Dai B, Sun TM, Mei CL, Liu SQ, Wu YM, Shen XF, et al. Expression of kerathocyte growth factor in renal cystic tissues of patients with autosomal dominan t polycystic kidney disease. Chin J Int Med (Chin) 2005; 44: 389-390.
26. Sun TM, Dai B, Mei CL, Liu SQ, Shen XF, Wang WJ, et al. Effect of keratinocyte growth factor on cell cycle and regulatory protein of cyst-lining epithelia in autosomal dominant polycystic kidney disease. J Nephrol Dialy Transplant (Chin) 2003; 12: 516-519.
27. Mei C, Mao Z, Shen X, Wang W, Dai B, Tang B, et al. Role of keratinocyte growth factor in the pathogenesis of autosomal dominant polycystic kidney disease. Nephrol Dial Transplan 2005; 20: 2368-2375.
28. Wu YM, Mei CL, Sun TM, Zhang JQ, Zhang L, Song J, et al. Role of insulin-like growth factor-1 in the pathogenesis of autosomal dominant polycystic kidney disease. Chin J Nephrol (Chin) 2004; 20: 290-294.
29. Shen XF, Mai CL, Sun TM, Zhang Y, Li DQ. Expression of Cyr61 in renal tissues of patients with autosomal dominant polycystic, kidney disease. Chin J Nephrol (Chin) 2004; 20: 421-424.
30. Wang WJ, Tang B, Mei CL, Sun TM, Li ZY, Shen XF, et al. Concentration of SPARC in body fluid and its expression in kidney tissues of patients with autosomal dominant polycystic kidney diseas. Chin J Nephrol (Chin) 2004; 20(S): 63-67.
31. Shen XF, Mei CL, Zhang Y, Liu YW, Dai B, Xu T, et al. Effect of over-expressed Cyr61 on expression of extracellular matrix of human renal tubular epithelial cells. Med J Chin PLA (Chin) 2005; 30: 280-282.
32. Wang WJ, Mei CL, Sun TM, Tang B, Li ZY, Xu CG. Effect of SPARC on cell cycle and regulatory gene of cyst-lining epithelial cells in autosomal dominant polycystic kidney diseas. Chin J Nephrol (Chin) 2005; 21: 108-111.
33. Wang W, Mai C, Tang B, Zhao H, Xu C, Li Z, et al. Aberrant expression of SPARC and its impact on proliferation and apoptosis in ADPKD cyst-lining epithelia. Nephrol Dial Transplant 2006; 21: 1278-1288.
34. Wang LM, Min ZL, Zhu YH, Qi J, Liao MM, Chen JH, et al. Gene diagnosis of autosomal dominant polycystic kidney disease I by means of rapid genetic analysis of SM7 microsatellite marker. Chin J Urol (Chin) 1998; 19: 158-160.
35. Wang LM, Min ZL, Zhu YH, Qi J, Liao MM, Chen JH, et al. The gene diagnosis and mutation survey of autosomal dominant polycystic kidney disease I. Acad J Sec Mil Med Univ (Chin) 1999; 20:137-141.
36. Zhang WL, Zhang DY, Wu YM, Sun TM, Mei CL. Gene diagnosis of autosomal dominant polycystic kidney disease type 2 using microsatellite DNA tightly linked to polycystic kidney disease gene 2. Chin J Med Genet (Chin) 2004; 21: 325-328.
37. Phakdeekitcharoen B, Watnick TJ, Germino GG. Mutation analysis of the entire replicated portion of PKD1 using genomic DNA samples. J Am Soc Nephrol 2001; 12: 955-963.
38. Zhang SZ, Mei CL, Dai B, Sun TM, Zhao HD, Zhang DY, et al. Development and preliminary application of a systems for detecting the Hans PKD1 mutation. Chin J Lab Med (Chin) 2002; 25-215-219.
39. Zhang DY, Mei CL, Tang B, Zhang SZ, Zhang WL, Dai B, et al. Detection of the mutations of autosomal dominant polycystic kidney disease gene 2 in Chinese. Chin J Nephrol (Chin) 2004; 20: 33-36.
40. Zhang S, Mei C, Zhang D, Dai B, Tang B, Sun T, et al. Mutation analysis of autosomal dominant polycystic kidney disease genes in Han Chinese. Nephron Exp Nephrol 2005; 100: e63-e76.
41. Zhang DY, Sun TM, Zhang SZ, Tang B, Dai B, Zhang WL, et al. Mutation detection of PKD2 gene in Chinese by denaturing high-performance liquid chromatograph. Chin J Med Genet (Chin) 2004; 21: 211-214.
42. Zhang SZ, Zhang YH, Zhang DY, Mei CL. Mutation detection of ADPKD PKD1 gene in Hans by denaturing high-performance liquid chromatography. Chin J Med Genet (Chin) 2006; 23: 283-288.
43. Qian Q, Harris PC, Torres VE. Treatment prospects for autosomal-dominant polycystic kidney disease. Kidney Int 2001; 59: 2005-2022.
44. Torres VE. Therapies to slow polycystic kidney disease. Nephron Exp Nephrol 2004; 98: e1-e7.
45. Sweeney WE, Futey L, Frost P, Avner ED. In vitro modulation of cyst formation by a novel tyrosine kinase inhibitor. Kidney Int 1999; 56: 406-413.
46. Sweeney WE, Chen Y, Nakanishi K. Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor. Kidney Int 2000; 57: 33-40.
47. Sweeney WE Jr, Hamahira K, Sweeney J, Garcia-Gatrell M, Frost P. Combination treatment of PKD utilizing dual inhibition of EGF-receptor activity and ligand bioavailability. Kidney Int 2003; 64: 1310-1319.
48. Torres VE, Sweeney WE Jr, Wang X, Qian Q, Harris PC, Frost P, et al. EGF receptor tyrosine kinase inhibition attenuates the development of PKD in Han: SPRD rats. Kidney Int 2003; 64: 1573-1579.
49. Li L, Zhao HD, Li GW, Chen J, Shen X, Mei CL. Expression purification and bioactivity determination of epidermal growth factor receptor protein tyrosine kinase. Acad J Sec Mil Med Univ (Chin) 2004; 25:1353-1356.
50. Li L, Sun TM, Mei CL, Xu CG, Zhao HD, Zhang SZ, et al. Effects of tyrosine kinase inhibitor CL-387, 785 on the proliferation and signal transduction pathway in human autosomal dominant polycystic kidney disease cyst-lining epithelial cells. Chin J Nephrol (Chin) 2003; 19: 339-343.
51. Muto S, Aiba A, Saito Y, Nakao K, Nakamura K, Tomita K, et al. Pioglitazone improves the phenotype and molecular defects of a targeted Pkd1 mutant. Hum Mol Genet 2002; 11: 1731-1742.
52. Xu CG, Mei CL, Ge SY, Sun TM. Effects of Sparganum stoloniferum Buch Ham on cell proliferation and phospholation of epithelial growth factor-receptor in ADPKD cystic-lining epithelial cells. Chin J Nephrol (Chin) 2002; 18: 38-40.
53. Xu CG, Mei CL, Zhao HD. Effect of eupolyphaga seu steleophaga on proliferation of autosomal dominant polycystic kidney disease cyst-lining epithelial cells. Acad J Sec Mil Med Univ (Chin) 2002; 23: 200-202.
54. Wang LM, Wang W, Min ZL, Zhu YH, Qi J. Therapeutic effect of immunosuppressant for adult polycystic kidney disease. Acad J Sec Mil Med Univ (Chin) 1999; 20: 541-543.
55. Li L, Fang P, Jing XC, Mei CL. Study on renal blood flow using color doppler ultrasound in polycystic kidney disease patients. Chin J Ultrasound Med (Chin) 2004; 20: 441-443.
56. Tang B, Mei CL, Zhang L, Zhang JQ, Sun TM, Zhang SZ. Relationship between renal volume and clinical presentations in autosomal dominant polycystic kdney disease. J Diagn Concepts Pract (Chin) 2003; 2: 290-292.
57. Hu ZQ, Chen JB, Wang Y, Zhou H, Zheng JH, Wang Q, et al. Clinical evaluation of laparoscopic renal cyst decortication for patients with autosomal dominant polycystic kidney disease. Acad J Sec Mil Med Univ (Chin) 2005; 26:107-108.
58. Zhu YH, Cui XG, Mei CL, Gao Y, Wang LM, Wang YW, et al. Clinical study on renal transplantation in polycystic kidney disease. Chin J Organ Transplant (Chin) 2004; 25: 114-116.